Conversation with Aimed Alliance Featured in Patient Empowerment Network Activity Guide on Health Policy
Aimed Alliance’s staff attorney, Ashira Vantrees, spoke with the Patient Empowerment Network for their May…
Browsing: State
FDA Sends Warning Letters to Four Companies for Selling Unapproved CBD Products
On May 26, the Food and Drug Administration (FDA) sent warning letters to Free State…
Report Examines Consequences of Non-Medical Switching for Patients with Mental Health Conditions
A new report from the Alliance for Mental Health Care Access entitled The Dangers of…
New Report Explains How Prescription Digital Therapies Differ From Wellness Apps
In May 2022, the Digital Therapeutics Alliance released a report titled DTx Value Assessment &…
Health Affairs Re-Releases Article on The Effects of Violence on Health
Whether directly or indirectly experienced, violence can have a negative impact on the health of…
New Study Provides Information on the Impact of CBD on Consumer’s Health
In March 2020, the U.S. Food and Drug Administration (FDA) recognized the need for more…
The American Hospital Association Calls for Action on Prior Authorizations in Medicare Advantage Plans
On May 19, 2022, the American Hospital Association (AHA) sent a letter to the Administrator…
CCSS Sends Letter of Support for Dietary Supplement Listing Act of 2022
On May 18, the Collaborative for Cannabinoid Science and Safety (CCSS) sent a letter to…
Aimed Alliance summarizes Johnson & Johnson’s lawsuit against SaveOnSP
On May 4, 2022, Johnson & Johnson filed a complaint in the United States District…
Aimed Alliance adds FAQ to Copay Accumulator 101 Hub
On May 15, 2022, Aimed Alliance updated its Copay Accumulator 101 Hub to include a…